Spry1 and Spry4 Differentially Regulate Human Aortic Smooth Muscle Cell Phenotype via Akt/FoxO/Myocardin Signaling

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Yang, Xuehui ^a   Gong, Yan ^a,b   Tang, Yuefeng ^a,b,d   Li, Hongfang ^c   He, Qing ^a,b   Gower, Lindsey ^a   Liaw, Lucy ^a,b   Friesel, Robert E ^a,b  

^a Maine Medical Center Research Institute   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c LANZHOU UNIVERSITY   (China)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYOCARDIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REGULATOR PROTEIN; SMALL INTERFERING RNA; SPRY1 PROTEIN; SPRY4 PROTEIN; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

AORTA; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION; GENETIC MARKER; HUMAN; HUMAN CELL; IN VITRO STUDY; MYOCARDIN GENE; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

AORTA; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MYOCYTES, SMOOTH MUSCLE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 84875016872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058746     Document Type: Article

References (35)

1. Owens GK (2007) Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found Symp 283: 174-191; discussion 191-173, 238-141.
2. Owens GK, Kumar MS, Wamhoff BR, (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
3. Brown DJ, Rzucidlo EM, Merenick BL, Wagner RJ, Martin KA, et al. (2005) Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation. J Vasc Surg 41: 509-516.
4. Chen PY, Simons M, Friesel R, (2009) FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression. J Biol Chem 284: 15980-15992.
5. Martin KA, Merenick BL, Ding M, Fetalvero KM, Rzucidlo EM, et al. (2007) Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem 282: 36112-36120.
6. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, et al. (2005) Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res 96: 172-179.
7. Thomas JA, Deaton RA, Hastings NE, Shang Y, Moehle CW, et al. (2009) PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol 296: H442-452.
8. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, et al. (2001) Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105: 851-862.
9. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, et al. (2004) Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428: 185-189.
10. Liu ZP, Wang Z, Yanagisawa H, Olson EN, (2005) Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev Cell 9: 261-270.
11. Edwin F, Anderson K, Ying C, Patel TB, (2009) Intermolecular interactions of Sprouty proteins and their implications in development and disease. Mol Pharmacol 76: 679-691.
12. Mason JM, Morrison DJ, Basson MA, Licht JD, (2006) Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 16: 45-54.
13. Impagnatiello MA, Weitzer S, Gannon G, Compagni A, Cotten M, et al. (2001) Mammalian sprouty-1 and-2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol 152: 1087-1098.
14. Lee SH, Schloss DJ, Jarvis L, Krasnow MA, Swain JL, (2001) Inhibition of angiogenesis by a mouse sprouty protein. J Biol Chem 276: 4128-4133.
15. de Alvaro C, Martinez N, Rojas JM, Lorenzo M, (2005) Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2. Mol Biol Cell 16: 4454-4461.
16. Shea KL, Xiang W, LaPorta VS, Licht JD, Keller C, et al. (2010) Sprouty1 regulates reversible quiescence of a self-renewing adult muscle stem cell pool during regeneration. Cell Stem Cell 6: 117-129.
17. Edwin F, Singh R, Endersby R, Baker SJ, Patel TB, (2006) The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation. J Biol Chem 281: 4816-4822.
18. Zhang C, Chaturvedi D, Jaggar L, Magnuson D, Lee JM, et al. (2005) Regulation of vascular smooth muscle cell proliferation and migration by human sprouty 2. Arterioscler Thromb Vasc Biol 25: 533-538.
19. Xie WB, Li Z, Miano JM, Long X, Chen SY, (2011) Smad3-mediated myocardin silencing: a novel mechanism governing the initiation of smooth muscle differentiation. J Biol Chem 286: 15050-15057.
20. Tan WQ, Wang K, Lv DY, Li PF, (2008) Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. J Biol Chem 283: 29730-29739.
21. Rached MT, Kode A, Silva BC, Jung DY, Gray S, et al. (2010) FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest 120: 357-368.
22. Gross I, Bassit B, Benezra M, Licht JD, (2001) Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem 276: 46460-46468.
23. Lao DH, Chandramouli S, Yusoff P, Fong CW, Saw TY, et al. (2006) A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation. J Biol Chem 281: 29993-30000.
24. Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, et al. (2003) Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Cell Cycle 2: 281-282.
25. Basson MA, Akbulut S, Watson-Johnson J, Simon R, Carroll TJ, et al. (2005) Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction. Dev Cell 8: 229-239.
26. Sathyanarayana P, Dev A, Pradeep A, Ufkin M, Licht JD, et al. (2012) Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2. Blood 119: 5522-5531.
27. Yang X, Harkins LK, Zubanova O, Harrington A, Kovalenko D, et al. (2008) Overexpression of Spry1 in chondrocytes causes attenuated FGFR ubiquitination and sustained ERK activation resulting in chondrodysplasia. Dev Biol 321: 64-76.
28. Wong ES, Fong CW, Lim J, Yusoff P, Low BC, et al. (2002) Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J 21: 4796-4808.
29. Lito P, Mets BD, Kleff S, O'Reilly S, Maher VM, et al. (2008) Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts. J Biol Chem 283: 2002-2009.
30. Ozaki K, Miyazaki S, Tanimura S, Kohno M, (2005) Efficient suppression of FGF-2-induced ERK activation by the cooperative interaction among mammalian Sprouty isoforms. J Cell Sci 118: 5861-5871.
31. Cook CL, Weiser MC, Schwartz PE, Jones CL, Majack RA, (1994) Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res 74: 189-196.
32. Owens GK, Thompson MM, (1986) Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. J Biol Chem 261: 13373-13380.
33. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, et al. (1993) Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 73: 223-231.
34. Tamama K, Sen CK, Wells A, (2008) Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev 17: 897-908.
35. Creemers EE, Sutherland LB, McAnally J, Richardson JA, Olson EN, (2006) Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 133: 4245-4256.